We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
REFERENCES
1
1.Bolton, DC, McKinley, MP, Prusiner, SB. Identification of a protein that putifies with the scrapie prion. Science. 1982;218:1309–1311.Google Scholar
2
2.Merrill, DA, Roberts, JA, Tuszynski, MH. Conservation of neuron number and size in entorhinal cortex layers II, III, and V/VI of aged primates. J Comp Neurol. 2000;422:396–401.Google Scholar
3
3.Schenk, D, Barbour, R, Dunn, W, et al.Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400:173–177.Google Scholar
4
4.Kordower, JH, Emborg, ME, Bloch, J, et al.Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000;290:767–773.Google Scholar
5
5.Olanow, CW, Schapira, AH, Agid, Y. Neuroprotection for Parkinson's disease: prospects and promises. Ann Neurol. 2003;53:S1–S2.Google Scholar
6
6.Vorel, SR, Liu, X, Hayes, RJ, et al.Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science. 2001;292:1175–1178.CrossRefGoogle ScholarPubMed
7
7.Geyer, MA, Markou, A. Animal models in psychiatric disorders. In: Bloom, FE, Kupfer, DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1955:787–798.Google Scholar